pyrroles has been researched along with ATLL in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartholdy, B; Chung, EY; Ishida, E; Janakiram, M; Kataoka, K; Mai, Y; Ogawa, S; Pradhan, K; Ren, X; Shah, UA; Steidl, U; Verma, A; Wei, X; Wei, Y; Ye, BH; Zang, X; Zhang, J; Zou, Y | 1 |
| Waldmann, TA | 1 |
| Bryant, BR; Chen, J; Jacobson, S; Janik, JE; Jiang, JK; Ju, W; Morris, JC; Oh, U; Sato, N; Tagaya, Y; Thomas, CJ; Waldmann, TA; Zhang, M | 1 |
| Ananth, SL; Bantia, S; Horn, LL; Parker, CD; Upshaw, R | 1 |
| Brown, Z; Cronshaw, DG; Kouroumalis, A; Parry, R; Ward, SG; Webb, A | 1 |
| Gandhi, V; Ravandi, F | 1 |
2 review(s) available for pyrroles and ATLL
| Article | Year |
|---|---|
The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders.
Topics: Alopecia Areata; Animals; Antibodies, Monoclonal; Autoimmune Diseases; Humans; Interleukin-15; Leukemia-Lymphoma, Adult T-Cell; Neoplasms; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Receptors, Interleukin-15; Signal Transduction | 2013 |
Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphoma.
Topics: Adult; Animals; Antimetabolites, Antineoplastic; Arabinonucleosides; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Deoxyguanosine; Drug Design; Drug Screening Assays, Antitumor; Drugs, Investigational; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Experimental; Lymphoma, T-Cell; Mice; Neoplasm Proteins; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; T-Lymphocytes | 2006 |
4 other study(ies) available for pyrroles and ATLL
| Article | Year |
|---|---|
PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma.
Topics: Adult; Animals; Cell Adhesion; Cell Adhesion Molecule-1; Cell Line, Tumor; Cell Proliferation; Female; Gene Amplification; Humans; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Inbred NOD; Mice, SCID; p21-Activated Kinases; Primary Cell Culture; Protein Kinase Inhibitors; Pyrazoles; Pyrroles; RNA, Small Interfering; Survival Rate; Xenograft Model Antitumor Assays | 2019 |
CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
Topics: Adult; Animals; Cell Line, Tumor; Cell Proliferation; Cytokines; Enzyme Activation; Humans; In Vitro Techniques; Interleukin-15; Janus Kinase 3; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Experimental; Mice; Mice, Inbred NOD; Mice, SCID; Mice, Transgenic; Paraparesis, Tropical Spastic; Phosphorylation; Piperidines; Pyrimidines; Pyrroles; Signal Transduction; STAT5 Transcription Factor; T-Lymphocytes | 2011 |
Mechanism of inhibition of T-acute lymphoblastic leukemia cells by PNP inhibitor--BCX-1777.
Topics: Apoptosis; Cell Division; Cell Line; Culture Media; Half-Life; HIV Reverse Transcriptase; Humans; Lamivudine; Leukemia-Lymphoma, Adult T-Cell; Lymphocytes; Purine Nucleosides; Purine-Nucleoside Phosphorylase; Pyrimidinones; Pyrroles; Reverse Transcriptase Inhibitors; Stavudine | 2003 |
Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
Topics: Acetophenones; Benzopyrans; Calcium; Calcium Channels; Calcium Signaling; Catalytic Domain; Cell Line, Tumor; Chemokine CCL17; Chemokine CCL22; Chemokines, CC; Chemotaxis; Chromones; Diglycerides; Estrenes; Humans; Indoles; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Leukemia-Lymphoma, Adult T-Cell; Morpholines; Pertussis Toxin; Phosphatidylinositol 3-Kinases; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Phosphothreonine; Protein Processing, Post-Translational; Pyrroles; Pyrrolidinones; Receptors, CCR4; Receptors, Chemokine; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; T-Lymphocytes; Th2 Cells | 2006 |